News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,099 Results
Type
Article (14246)
Company Profile (100)
Press Release (252753)
Section
Business (88689)
Career Advice (495)
Deals (15497)
Drug Delivery (64)
Drug Development (37504)
Employer Resources (56)
FDA (6406)
Job Trends (6288)
News (151973)
Policy (14196)
Tag
Academia (474)
Alliances (23340)
Alzheimer's disease (382)
Approvals (6415)
Artificial intelligence (83)
Bankruptcy (144)
Best Places to Work (4446)
Breast cancer (68)
Cancer (492)
Cardiovascular disease (54)
Career advice (431)
Cell therapy (77)
Clinical research (31405)
Collaboration (260)
Compensation (105)
COVID-19 (835)
C-suite (82)
Data (477)
Diabetes (66)
Diagnostics (1307)
Drug discovery (46)
Drug pricing (61)
Earnings (31996)
Employer resources (47)
Events (37513)
Executive appointments (292)
FDA (6693)
Funding (170)
Gene therapy (84)
GLP-1 (332)
Government (1339)
Healthcare (3691)
Infectious disease (864)
Inflammatory bowel disease (50)
Interviews (64)
IPO (5925)
Job creations (2065)
Job search strategy (394)
Layoffs (180)
Legal (3438)
Lung cancer (67)
Manufacturing (123)
Medical device (1355)
Medtech (1357)
Mergers & acquisitions (9703)
Metabolic disorders (212)
Neuroscience (532)
NextGen: Class of 2025 (1622)
Non-profit (624)
Northern California (599)
Obesity (126)
Opinion (119)
Patents (73)
People (28835)
Pharmaceutical (64)
Phase I (8256)
Phase II (13260)
Phase III (11892)
Pipeline (265)
Policy (51)
Postmarket research (1420)
Preclinical (3253)
Radiopharmaceuticals (118)
Rare diseases (134)
Real estate (2650)
Regulatory (10075)
Research institute (580)
Resumes & cover letters (60)
Southern California (565)
Startups (1642)
United States (5737)
Vaccines (151)
Weight loss (95)
Date
Today (79)
Last 7 days (282)
Last 30 days (1136)
Last 365 days (12677)
2025 (1189)
2024 (12779)
2023 (14566)
2022 (19905)
2021 (20510)
2020 (19361)
2019 (15172)
2018 (11989)
2017 (14065)
2016 (13323)
2015 (15681)
2014 (12566)
2013 (10685)
2012 (11508)
2011 (12037)
2010 (10974)
Location
Africa (318)
Asia (20155)
Australia (2629)
California (1388)
Canada (757)
China (177)
Colorado (58)
Connecticut (56)
Europe (39647)
Florida (240)
Illinois (155)
Indiana (107)
Japan (66)
Kansas (54)
Maryland (203)
Massachusetts (1185)
Minnesota (77)
New Jersey (583)
New York (387)
North Carolina (328)
Northern California (599)
Pennsylvania (352)
South America (510)
Southern California (565)
Texas (178)
Virginia (53)
Washington State (90)
267,099 Results for "peak pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oracle Recognized as a Leader in Everest Group PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) Assessment 2024
February 3, 2025
·
5 min read
Immuron CEO Steven Lydeamore to present at Peak Sky High
Immuron Limited, an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will be presenting at Peak Asset Management’s Peak Sky High luncheon in Melbourne on June 1, 2024.
May 31, 2024
·
6 min read
Press Releases
Axsendo Clinical Research (ACR) is proud to announce a new research partnership with Peak Heart & Vascular
January 15, 2025
·
1 min read
Press Releases
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Deals
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Akari Therapeutics, Plc and Peak Bio Inc. announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC platform technology and Akari’s PAS-nomacopan Geographic Atrophy program.
May 1, 2024
·
16 min read
Press Releases
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
November 15, 2024
·
8 min read
Press Releases
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
November 8, 2024
·
12 min read
Biotech Beach
Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials
Bright Peak Therapeutics, a biotechnology company developing next-generation, multifunctional immunotherapies, announced that it raised $90 million in a Series C financing.
June 11, 2024
·
2 min read
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
STERIS plc announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million.
April 11, 2024
·
9 min read
Press Releases
Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 8, 2024
·
3 min read
1 of 26,710
Next
